Skip to main content
Commonwealth of Virginia branding bar cardinal logo

Virginia.gov

A design prototype by Datopian, not an official website

Find a Commonwealth Resource

Datasets

1,977 datasets

HealthData.Gov

LymeX Patient-Centered Innovation

Join HHS and LymeX collaborators at LymeX.crowdicity.com to cocreate solutions for Lyme disease with patients as partners and, together, disrupt the Lyme status quo.

Updated Oct 29, 2026

HealthData.Gov

LymeX Innovation Accelerator

Visit the official HHS page for the LymeX partners: Lyme-X.org to learn how HHS and the Steven & Alexandra Cohen Foundation are, together, disrupting the Lyme status quo.

Updated Oct 29, 2026

HealthData.Gov

LymeX Patient-Centered Innovation

Join HHS and LymeX collaborators at LymeX.crowdicity.com to cocreate solutions for Lyme disease with patients as partners and, together, disrupt the Lyme status quo.

Updated Dec 27, 2025

HealthData.Gov

LymeX Innovation Accelerator

Visit the official HHS page for the LymeX partners: Lyme-X.org to learn how HHS and the Steven & Alexandra Cohen Foundation are, together, disrupting the Lyme status quo.

Updated Dec 27, 2025

HealthData.Gov

LymeX Diagnostics Prize

Learn more about the LymeX Diagnostics Prize $10+ million competition to accelerate the development of Lyme disease diagnostics at LymeXdiagnosticsprize.com .

Updated Oct 29, 2026

HealthData.Gov

HHS Invisible Illness Initiative: Lyme Disease

Visit the official HHS page for Lyme disease: HHS.gov/Lyme to learn how HHS is responding to Lyme disease with increased investments, comprehensive research, improved diagnostic tools, patient-centered solutions, and…

Updated Oct 29, 2026

HealthData.Gov

Invisible Illness Patient-Centered Innovation

Join HHS and LymeX collaborators at invisibleillness.crowdicity.com to cocreate solutions with patients as partners for Long COVID, Lyme disease, ME/CFS, and other complex chronic conditions that are often invisible…

Updated Oct 29, 2026

HealthData.Gov

Patent AT-E401343-T1: [Translated] TOLEROGENIC PEPTIDES

There is provided a tolerogenic human peptide, capable of binding to an MHC class I or II molecule without further antigen processing, for use in the treatment and/or prevention of multiple sclerosis, which peptide is…

  • HTML

Updated Oct 29, 2026

HealthData.Gov

Patent AT-E400274-T1: [Translated] ACT ACTIVITY INHIBITORS

The present invention is directed to compounds comprising a 2,3-diphenylquinoxaline moiety which inhibit the activity of Akt, a serine/threonine protein kinase. The invention is further directed to chemotherapeutic…

  • HTML

Updated Oct 29, 2026

Prototype by Datopian · not an official government website · data from data.virginia.gov